Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial.

Schwalm JD, McCready T, Lopez-Jaramillo P, Yusoff K, Attaran A, Lamelas P, Camacho PA, Majid F, Bangdiwala SI, Thabane L, Islam S, McKee M, Yusuf S.

Lancet. 2019 Aug 30. pii: S0140-6736(19)31949-X. doi: 10.1016/S0140-6736(19)31949-X. [Epub ahead of print]

PMID:
31488369
2.

Frontier injustice: the American threat to Canada's drug supply.

Houston AR, Attaran A.

Can J Public Health. 2019 Jul 8. doi: 10.17269/s41997-019-00238-9. [Epub ahead of print]

PMID:
31286463
3.

Chronic exposure to dietary selenomethionine dysregulates the genes involved in serotonergic neurotransmission and alters social and antipredator behaviours in zebrafish (Danio rerio).

Attaran A, Salahinejad A, Crane AL, Niyogi S, Chivers DP.

Environ Pollut. 2019 Mar;246:837-844. doi: 10.1016/j.envpol.2018.12.090. Epub 2018 Dec 28.

PMID:
30623840
4.

Toward Point-of-Care Drug Quality Assurance in Developing Countries: Comparison of Liquid Chromatography and Infrared Spectroscopy Quantitation of a Small-Scale Random Sample of Amoxicillin.

Alotaibi N, Overton S, Curtis S, Nickerson JW, Attaran A, Gilmer S, Mayer PM.

Am J Trop Med Hyg. 2018 Aug;99(2):477-481. doi: 10.4269/ajtmh.17-0779. Epub 2018 Jun 7.

5.

An Analysis of Substandard Propofol Detected in Use in Zambian Anesthesia.

Mumphansha H, Nickerson JW, Attaran A, Overton S, Curtis S, Mayer P, Bould MD.

Anesth Analg. 2017 Aug;125(2):616-619. doi: 10.1213/ANE.0000000000002226. Erratum in: Anesth Analg. 2018 Dec;127(6):e113.

PMID:
28682949
6.

In which developing countries are patents on essential medicines being filed?

Beall RF, Blanchet R, Attaran A.

Global Health. 2017 Jun 26;13(1):38. doi: 10.1186/s12992-017-0262-4.

7.

A method for understanding generic procurement of HIV medicines by developing countries with patent protection.

Beall RF, Attaran A.

Soc Sci Med. 2017 Jul;185:118-126. doi: 10.1016/j.socscimed.2017.05.012. Epub 2017 May 4.

PMID:
28578209
8.

Erratum to: Access to controlled medicines for anesthesia and surgical care in low-income countries: a narrative review of international drug control systems and policies.

Nickerson JW, Pettus K, Wheeler KE, Hallam C, Bewley-Taylor DR, Attaran A, Gelb AW.

Can J Anaesth. 2017 May;64(5):558. doi: 10.1007/s12630-017-0836-x. No abstract available.

PMID:
28315165
9.

Access to controlled medicines for anesthesia and surgical care in low-income countries: a narrative review of international drug control systems and policies.

Nickerson JW, Pettus K, Wheeler KE, Hallam C, Bewley-Taylor DR, Attaran A, Gelb AW.

Can J Anaesth. 2017 Mar;64(3):296-307. doi: 10.1007/s12630-016-0805-9. Epub 2017 Jan 3. Erratum in: Can J Anaesth. 2017 May;64(5):558.

PMID:
28050803
10.

Which patent and where? Why international patent transparency by companies is needed for medicines.

Beall RF, Attaran A.

Nat Biotechnol. 2016 Sep 8;34(9):923-6. doi: 10.1038/nbt.3664. No abstract available.

PMID:
27606455
11.

Could patents interfere with the development of a cardiovascular polypill?

Beall RF, Schwalm JD, Huffman MD, McCready T, Yusuf S, Attaran A.

J Transl Med. 2016 Aug 18;14(1):242. doi: 10.1186/s12967-016-0997-3.

12.

The olympically mismeasured risk of Zika virus in Rio de Janeiro.

Attaran A, Caplan A, Igel L.

Lancet. 2016 Aug 13;388(10045):657-8. doi: 10.1016/S0140-6736(16)31227-2. Epub 2016 Jul 30. No abstract available.

PMID:
27480044
13.

Zika virus and the 2016 Olympic Games.

Attaran A.

Lancet Infect Dis. 2016 Sep;16(9):1001-1003. doi: 10.1016/S1473-3099(16)30230-4. Epub 2016 Jul 23. No abstract available.

PMID:
27460685
14.
15.

Upstream solutions for price-gouging on critical generic medicines.

Houston AR, Beall RF, Attaran A.

J Pharm Policy Pract. 2016 May 2;9:15. doi: 10.1186/s40545-016-0064-8. eCollection 2016.

16.

Lowering the High Cost of Cancer Drugs--III.

Attaran A, Mackey T, Beall R.

Mayo Clin Proc. 2016 Mar;91(3):399-400. doi: 10.1016/j.mayocp.2015.12.012. No abstract available.

PMID:
26944246
17.

Is Patent "Evergreening" Restricting Access to Medicine/Device Combination Products?

Beall RF, Nickerson JW, Kaplan WA, Attaran A.

PLoS One. 2016 Feb 24;11(2):e0148939. doi: 10.1371/journal.pone.0148939. eCollection 2016.

18.

Mapping of Health Communication and Education Strategies Addressing the Public Health Dangers of Illicit Online Pharmacies.

Anderson AC, Mackey TK, Attaran A, Liang BA.

J Health Commun. 2016;21(4):397-407. doi: 10.1080/10810730.2015.1095816. Epub 2016 Feb 4. Review.

PMID:
26846423
19.

Fatal Bacterial Meningitis Possibly Associated with Substandard Ceftriaxone--Uganda, 2013.

Nickerson JW, Attaran A, Westerberg BD, Curtis S, Overton S, Mayer P.

MMWR Morb Mortal Wkly Rep. 2016 Jan 1;64(50-51):1375-7. doi: 10.15585/mmwr.mm6450a2.

20.

The Ebola Vaccine, Iatrogenic Injuries, and Legal Liability.

Attaran A, Wilson K.

PLoS Med. 2015 Dec 1;12(12):e1001911. doi: 10.1371/journal.pmed.1001911. eCollection 2015 Dec.

21.

Association of rule of law and health outcomes: an ecological study.

Pinzon-Rondon AM, Attaran A, Botero JC, Ruiz-Sternberg AM.

BMJ Open. 2015 Oct 29;5(10):e007004. doi: 10.1136/bmjopen-2014-007004.

22.

Assessments of health services availability in humanitarian emergencies: a review of assessments in Haiti and Sudan using a health systems approach.

Nickerson JW, Hatcher-Roberts J, Adams O, Attaran A, Tugwell P.

Confl Health. 2015 Jun 8;9:20. doi: 10.1186/s13031-015-0045-6. eCollection 2015.

23.

Compulsory Licenses: The Authors Reply.

Beall RF, Attaran A, Kuhn R.

Health Aff (Millwood). 2015 Jun;34(6):1068. doi: 10.1377/hlthaff.2015.0453. No abstract available.

PMID:
26056220
24.

Unanimity on death with dignity--legalizing physician-assisted dying in Canada.

Attaran A.

N Engl J Med. 2015 May 28;372(22):2080-2. doi: 10.1056/NEJMp1502442. No abstract available.

PMID:
26017821
25.

Stopping murder by medicine: introducing the Model Law on Medicine Crime.

Attaran A.

Am J Trop Med Hyg. 2015 Jun;92(6 Suppl):127-132. doi: 10.4269/ajtmh.15-0154. Epub 2015 Apr 20.

26.

Responding to the pandemic of falsified medicines.

Nayyar GML, Attaran A, Clark JP, Culzoni MJ, Fernandez FM, Herrington JE, Kendall M, Newton PN, Breman JG.

Am J Trop Med Hyg. 2015 Jun;92(6 Suppl):113-118. doi: 10.4269/ajtmh.14-0393. Epub 2015 Apr 20.

27.

Strategies to increase the ownership and use of insecticide-treated bednets to prevent malaria.

Augustincic Polec L, Petkovic J, Welch V, Ueffing E, Tanjong Ghogomu E, Pardo Pardo J, Grabowsky M, Attaran A, Wells GA, Tugwell P.

Cochrane Database Syst Rev. 2015 Mar 30;(3):CD009186. doi: 10.1002/14651858.CD009186.pub2. Review.

PMID:
25822171
28.

The Commission on Narcotic Drugs' attempt to restrict ketamine.

Nickerson JW, Attaran A.

Lancet. 2015 Mar 7;385(9971):e19. doi: 10.1016/S0140-6736(15)60490-1. No abstract available.

PMID:
25773098
29.

Trading health for oil? Uganda should not export its health workers.

Labonté R, Attaran A, Bourgeault I, Tomblin-Murphy G, Sanders D.

Lancet. 2015 Feb 28;385(9970):e13. doi: 10.1016/S0140-6736(15)60442-1. No abstract available.

PMID:
25752184
30.

Compulsory licensing often did not produce lower prices for antiretrovirals compared to international procurement.

Beall RF, Kuhn R, Attaran A.

Health Aff (Millwood). 2015 Mar;34(3):493-501. doi: 10.1377/hlthaff.2014.0658.

PMID:
25732501
31.

Is Canada patent deal obstructing Ebola vaccine development?

Attaran A, Nickerson JW.

Lancet. 2014 Nov 29;384(9958):e61. No abstract available.

PMID:
25467593
32.

Pan-Canadian overpricing of medicines: a 6-country study of cost control for generic medicines.

Beall RF, Nickerson JW, Attaran A.

Open Med. 2014 Oct 14;8(4):e130-5. eCollection 2014. No abstract available.

33.

A call for a moratorium on the .health generic top-level domain: preventing the commercialization and exclusive control of online health information.

Mackey TK, Eysenbach G, Liang BA, Kohler JC, Geissbuhler A, Attaran A.

Global Health. 2014 Sep 26;10:62. doi: 10.1186/s12992-014-0062-z.

34.

A modest but meaningful decision for Indian drug patents.

Attaran A.

Lancet. 2014 Aug 9;384(9942):477-9. doi: 10.1016/S0140-6736(13)60845-4. Epub 2014 Jun 26. No abstract available.

PMID:
24976117
35.

Monitoring the ability to deliver care in low- and middle-income countries: a systematic review of health facility assessment tools.

Nickerson JW, Adams O, Attaran A, Hatcher-Roberts J, Tugwell P.

Health Policy Plan. 2015 Jun;30(5):675-86. doi: 10.1093/heapol/czu043. Epub 2014 Jun 3. Review.

36.

Access to controlled medicines for pain relief and anaesthesia in low-income countries.

Nickerson JW, Attaran A.

Lancet. 2014 May 24;383(9931):1802. doi: 10.1016/S0140-6736(14)60874-6. No abstract available.

PMID:
24856020
37.

Response to: Bouwman, H. et al. Hallogenated pollutants in terrestrial and aquatic bird eggs: converging patterns of pollutant profiles, and impacts and risks from higher levels Environ. Res. (2013) http://dx.doi.org/10.1016/j.envres.2013.06.003.

Roberts DR, Maharaj R, Coetzee M, Hunt RH, Govere J, Tren R, Urbach J, Attaran A, Blumberg L.

Environ Res. 2014 Jul;132:457-8. doi: 10.1016/j.envres.2014.01.010. Epub 2014 Apr 28.

PMID:
24784543
38.

Health domains for sale: the need for global health Internet governance.

Mackey TK, Liang BA, Kohler JC, Attaran A.

J Med Internet Res. 2014 Mar 5;16(3):e62. doi: 10.2196/jmir.3276.

39.

Webcast the world health assembly.

Attaran A, Benton D, Chauvin J, McKee M, Percival V.

Lancet. 2014 Jan 11;383(9912):125-6. doi: 10.1016/S0140-6736(14)60023-4. No abstract available.

PMID:
24411968
40.

Universal health coverage and health laws.

Attaran A, Capron AM.

Lancet. 2014 Jan 4;383(9911):25. doi: 10.1016/S0140-6736(13)62724-5. No abstract available.

PMID:
24388300
41.

Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges.

Working Group on the Summit on Combination Therapy for CVD, Yusuf S, Attaran A, Bosch J, Joseph P, Lonn E, McCready T, Mente A, Nieuwlaat R, Pais P, Rodgers A, Schwalm JD, Smith R, Teo K, Xavier D.

Eur Heart J. 2014 Feb;35(6):353-64. doi: 10.1093/eurheartj/eht407. Epub 2013 Nov 27. Review.

PMID:
24288261
42.

Enzyme-assisted extraction and ionic liquid-based dispersive liquid-liquid microextraction followed by high-performance liquid chromatography for determination of patulin in apple juice and method optimization using central composite design.

Mohammadi A, Tavakoli R, Kamankesh M, Rashedi H, Attaran A, Delavar M.

Anal Chim Acta. 2013 Dec 4;804:104-10. doi: 10.1016/j.aca.2013.09.045. Epub 2013 Sep 26.

PMID:
24267070
43.

Ensuring the future of health information online.

Mackey TK, Liang BA, Attaran A, Kohler JC.

Lancet. 2013 Oct 26;382(9902):1404. doi: 10.1016/S0140-6736(13)62215-1. Epub 2013 Oct 25. No abstract available.

PMID:
24243134
44.

Combatting substandard and falsified medicines: a view from Rwanda.

Binagwaho A, Bate R, Gasana M, Karema C, Mucyo Y, Mwesigye JP, Biziyaremye F, Nutt CT, Wagner CM, Jensen P, Attaran A.

PLoS Med. 2013;10(7):e1001476. doi: 10.1371/journal.pmed.1001476. Epub 2013 Jul 2. No abstract available.

45.

Molecularly imprinted solid-phase extraction for selective trace analysis of trifluoperazine.

Attaran AM, Mohammadi N, Javanbakht M, Akbari-Adergani B.

J Chromatogr Sci. 2014 Aug;52(7):730-8. doi: 10.1093/chromsci/bmt074. Epub 2013 Jun 19.

PMID:
23788020
46.

Solvent-assisted dispersive micro-SPE by using aminopropyl-functionalized magnetite nanoparticle followed by GC-PID for quantification of parabens in aqueous matrices.

Abbasghorbani M, Attaran A, Payehghadr M.

J Sep Sci. 2013 Jan;36(2):311-9. doi: 10.1002/jssc.201200556. Epub 2012 Nov 29.

PMID:
23197331
47.

How to achieve international action on falsified and substandard medicines.

Attaran A, Barry D, Basheer S, Bate R, Benton D, Chauvin J, Garrett L, Kickbusch I, Kohler JC, Midha K, Newton PN, Nishtar S, Orhii P, McKee M.

BMJ. 2012 Nov 13;345:e7381. doi: 10.1136/bmj.e7381. No abstract available.

48.

The UN is premature in trying to ban DDT for malaria control.

Tren R, Kamwi RN, Attaran A.

BMJ. 2012 Oct 10;345:e6801. doi: 10.1136/bmj.e6801. No abstract available.

PMID:
23054354
49.

Subsidizing artemisinin-based combination therapies: a preliminary investigation of the Affordable Medicines Facility - malaria.

Bate R, Hess K, Tren R, Mooney L, Cudjoe F, Ayodele T, Attaran A.

Res Rep Trop Med. 2012 Jul 17;3:63-68. doi: 10.2147/RRTM.S33690. eCollection 2012.

50.

Anti-infective medicine quality: analysis of basic product quality by approval status and country of manufacture.

Bate R, Mooney L, Hess K, Milligan J, Attaran A.

Res Rep Trop Med. 2012 Jul 13;3:57-61. doi: 10.2147/RRTM.S33108. eCollection 2012. Review.

Supplemental Content

Loading ...
Support Center